Epitomics' novel cancer-related antibodies were developed through a partnership with the National Cancer Institute's Center for Cancer Research.
The goal of the partnership was to develop novel, high-quality reagents for cancer research and make them available to the scientific community. The 23 antibodies already made under the collaboration are available for purchase in the USA directly through Epitomics and around the world through Epitomics international distributors. It is anticipated that another 20 antibodies will be developed through this partnership and released by Epitomics over the next 2 years.
This Product is made by: